| Company Name | Date | Purpose |
|
Chennai Meena
|
09-Jan-26
| Chennai Meenakshi Multispeciality Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2026 inter alia to consider and approve Notice pursuant to relevant Regulation(s) of SEBI (Listing Obligations and disclosure Requirements) Regulations 2015 (LODR) NOTICE is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held at 11.30 A.M on Friday 9th day of January 2026 at the Registered Office of the Company at New No.70 Old No.149 Luz Church Road Mylapore Chennai-600 004 inter-alia to consider approve the appointment of Mrs. M.S. Anantha Lakshmi B. Com ACS ACMA MBA as Company Secretary and Compliance Officer of the Company among other subjects if any. |
|
Cian Healthcare
|
09-Jan-26
| Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2026 inter alia to consider and approve a) the record date for reduction/cancellation and extinguishment of existing equity shares held by the erstwhile promoters and existing public shareholders of the Company (existing equity paid-up share capital); and
b) issuance of equity shares on a preferential basis to the prospective promoters in compliance with the NCLT Order read with Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 as amended from time to time. |
|
Faalcon Concepts
|
09-Jan-26
| Faalcon Concepts Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2026 inter alia to consider and approve As per file attached |
|
G G Engineering
|
09-Jan-26
| G G Engineering Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2026 inter alia to consider and approve Intimation of Board Meeting to be held on January 09 2026 |
|
Globus Spirits
|
09-Jan-26
| Globus Spirits Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2026 inter alia to consider and approve Financial results for the quarter ending 31st Dec 2025 |
| Prev | Next |